WO2007149500A3 - Formulations containing hybrid dendrimers - Google Patents

Formulations containing hybrid dendrimers Download PDF

Info

Publication number
WO2007149500A3
WO2007149500A3 PCT/US2007/014402 US2007014402W WO2007149500A3 WO 2007149500 A3 WO2007149500 A3 WO 2007149500A3 US 2007014402 W US2007014402 W US 2007014402W WO 2007149500 A3 WO2007149500 A3 WO 2007149500A3
Authority
WO
WIPO (PCT)
Prior art keywords
different
hybrid
dendrimers
guest
hybrid dendrimers
Prior art date
Application number
PCT/US2007/014402
Other languages
French (fr)
Other versions
WO2007149500A2 (en
WO2007149500A9 (en
Inventor
Abhay Singh Chauhan
Sonke Svenson
Original Assignee
Dendritic Nanotechnologies Inc
Abhay Singh Chauhan
Sonke Svenson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dendritic Nanotechnologies Inc, Abhay Singh Chauhan, Sonke Svenson filed Critical Dendritic Nanotechnologies Inc
Publication of WO2007149500A2 publication Critical patent/WO2007149500A2/en
Publication of WO2007149500A9 publication Critical patent/WO2007149500A9/en
Publication of WO2007149500A3 publication Critical patent/WO2007149500A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen

Abstract

The present invention concerns hybrid dendrimers comprising a mixture, at the same or different ratios, of at least two dendritic polymers or dendronized polymers that have at least one difference between them. The surfaces of the dendritic polymer or dendronized polymer may be further modified by known methods. Also included are formulations of hybrid dendrimers wherein the dendritic polymers have the same drug present at either identical or different loading concentrations but have different release profiles. Such formulations of hybrid dendrimers may have different guest molecules present at either identical or different loading concentrations but have different release profiles. Additionally a method of using a hybrid dendrimer for delivery of a drug or guest moiety in order to provide increased solubility to poorly soluble drugs or guest moieties is provided.
PCT/US2007/014402 2006-06-21 2007-06-20 Formulations containing hybrid dendrimers WO2007149500A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81551906P 2006-06-21 2006-06-21
US60/815,519 2006-06-21

Publications (3)

Publication Number Publication Date
WO2007149500A2 WO2007149500A2 (en) 2007-12-27
WO2007149500A9 WO2007149500A9 (en) 2008-03-20
WO2007149500A3 true WO2007149500A3 (en) 2008-10-30

Family

ID=38834107

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/014402 WO2007149500A2 (en) 2006-06-21 2007-06-20 Formulations containing hybrid dendrimers

Country Status (1)

Country Link
WO (1) WO2007149500A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013177223A1 (en) 2012-05-21 2013-11-28 The Administrators Of The Tulane Educational Fund Tuned synthetic dendrimer calibrants for mass spectrometry
BR112018012244B1 (en) 2015-12-16 2022-02-01 Priostar Pty Ltd Formulation, method for controlling a pest, and use
WO2017216768A1 (en) 2016-06-16 2017-12-21 Association For The Advancement Of Tissue Engineering And Cell Based Technologies And Therapies - A4Tec Dendrimer-derived artificial antigen, methods and uses thereof
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4694064A (en) * 1986-02-28 1987-09-15 The Dow Chemical Company Rod-shaped dendrimer
US5714166A (en) * 1986-08-18 1998-02-03 The Dow Chemical Company Bioactive and/or targeted dendrimer conjugates

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4694064A (en) * 1986-02-28 1987-09-15 The Dow Chemical Company Rod-shaped dendrimer
US5714166A (en) * 1986-08-18 1998-02-03 The Dow Chemical Company Bioactive and/or targeted dendrimer conjugates

Also Published As

Publication number Publication date
WO2007149500A2 (en) 2007-12-27
WO2007149500A9 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
Du et al. pH-sensitive degradable chimaeric polymersomes for the intracellular release of doxorubicin hydrochloride
Louage et al. Well‐Defined Polymer–Paclitaxel Prodrugs by a Grafting‐from‐Drug Approach
WO2008124639A3 (en) Poly (amino acid) targeting moieties
WO2007084460A3 (en) Pharmaceutical compositions with enhanced stability
Yamamoto et al. What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core
Greene et al. Poly (acrylic acid-b-styrene) amphiphilic multiblock copolymers as building blocks for the assembly of discrete nanoparticles
JO2932B1 (en) Pegylated insulin lispro compounds
Louage et al. Degradable ketal-based block copolymer nanoparticles for anticancer drug delivery: a systematic evaluation
WO2006113679A3 (en) Delivery of sirna by neutral lipid compositions
Liang et al. Peptide‐tunable drug cytotoxicity via one‐step assembled polymer nanoparticles
WO2007133807A3 (en) Polymers for functional particles
WO2009021017A3 (en) Nucleic acid-lipopolymer compositions
MX2011006771A (en) Preparation method of polymeric micelles composition containing a poorly water-soluble drug.
WO2009143412A3 (en) Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides
MY149627A (en) Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same
WO2008138755A3 (en) Pharmaceutical compositions for poorly soluble drugs
WO2007099397A3 (en) Aliphatic polyester-amide compositions and a process for producing the same
Hwang et al. Novel poly (2-oxazoline) block copolymer with aromatic heterocyclic side chains as a drug delivery platform
WO2007149500A3 (en) Formulations containing hybrid dendrimers
CU23556A1 (en) POLYMER STRUCTURE SIMILAR TO DENDRÍMERO FOR THE OBTAINING OF CONJUGATES OF PHARMACEUTICAL INTEREST
Cheng et al. Synthesis and characterization of star-shaped block copolymer of poly-(ɛ-caprolactone) and poly (ethyl ethylene phosphate) as drug carrier
WO2010138544A3 (en) Oral care formulations that enhance amount of soluble zinc
ATE524510T1 (en) POLYANILINE, METHOD FOR THE PRODUCTION THEREOF AND SOLUTION CONTAINING POLYANILINE AND COATING MATERIAL
Holley et al. Block ionomer complexes consisting of siRNA and aRAFT-synthesized hydrophilic-block-cationic copolymers: the influence of cationic block length on gene suppression
Arslan et al. A modular and orthogonally reactive platform for fabrication of polymer–drug conjugates for targeted delivery

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07809729

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07809729

Country of ref document: EP

Kind code of ref document: A2